Blisibimod

Tax included
Blisibimod (A 623) is a potent and selective tetravalent inhibitor of B-cell activating factor (BAFF). Blisibimod can be used for the research of systemic lupus erythematosus (SLE).
MedChemExpress 
HY-P99482

Data sheet

Size
Multiple sizes
Reactivity
TNF Receptor
CAS
1236126-45-6